OM:SOBIBiotechs
Assessing Swedish Orphan Biovitrum’s Valuation After Full Year 2025 Earnings Pressure On Profitability
What Swedish Orphan Biovitrum’s latest earnings mean for investors
Swedish Orphan Biovitrum (OM:SOBI) has drawn fresh attention after reporting full year 2025 results, with sales of SEK 28,238 million, net income of SEK 478 million, and sharply lower earnings per share versus 2024.
See our latest analysis for Swedish Orphan Biovitrum.
Against this earnings backdrop, the share price has been firming, with a 7.37% 30 day share price return and a 9.47% 1 year total shareholder return. The 5 year...